Good morning! premarket watchlist 02/08 -Cleared Phase 1/2 Clinical Trial of Novel Cell Therapy (+99%), -Epromising preclinical mRNA vaccine data (+31%), -Meet the Nasdaqs Minimum Bid Price Requirement (+41%) -Integrates ChatGPT(+26%)